74
Articles Count
209974
Viewing Count
Minhua Chu

Dean of Research Institute

A growing number of drugmakers in China are on a q...
Minhua Chu · 4 days ago
Currently, 30 potential NASH drugs are in clinical studies in China, another eight candidates have submitted IND applications while six have already been greenlighted.
Further information
Feature
Not so kind: Kind Pharmaceuticals faces FibroGen’...
Minhua Chu · 10 days ago
On November 14, FibroGen filed a federal lawsuit in California alleging that two of its former employees stole its anemia treatment work and established company in China to develop me-too drugs and apply for patents.
Further information
Feature
Fundraising continued to drop in October, no drugm...
Minhua Chu · 21 days ago
September’s downward fundraising trend continued into October, with only 13 deals raising a total of $157 million.
Further information
China Biotech Fundraising Tracker
CanSino: Making the world’s first inhaled COVID-1...
Minhua Chu · 24 days ago
Chunlin Xin, Vice President of External Collaboration at CanSino Biologics, told PharmaDJ that “using the adenovirus type 5 vector may be the reason why we succeeded with making the world first inhaled COVID-19 vaccine.”
Further information
Feature
China clarifies regulations for online prescriptio...
Minhua Chu · 1 months ago
A new regulation now brings greater clarity to regulations around online prescription drug sales in China, bringing new opportunities and challenges to drugmakers.
Further information
Regulatory
Brii’s CNS Head: BRII-296 has potential to change...
Minhua Chu · 1 months ago
Aleksandar Skuban, Brii Bio’s Head of Central Nervous System (CNS) Disease Therapy Area, believes that BRII-296 has potential to provide a more appealing, convenient and less stigama treatment option for postpartum depression (PPD) patients.
Further information
Feature
Financing for China drugmakers hits the lowest of ...
Minhua Chu · 1 months ago
Financing for Chinese drugmakers hit a 2022 low with 15 of 19 companies disclosing a total of only $346 million in funding.
Further information
China Biotech Fundraising Tracker
Exclusive: Sirnaomics hopes to develop non-melanom...
Minhua Chu · 2 months ago
Sirnaomics’ Executive Director and Chief Medical Officer Dr. Michael Molyneaux talks with PharmaDJ about the future of its lead siRNA candidate, STP705.
Further information
Feature
Chinese pharma companies raised over half a billon...
Minhua Chu · 2 months ago
38 biotech companies secured financing this August, 31 of which disclosed figures totaling $563 million.
Further information
China Biotech Fundraising Tracker
In China, real-world evidence is playing an increa...
Minhua Chu · 2 months ago
Hainan’s Medical Tourism Pilot Zone is a pioneer in the practice, with three drugs already approved for market, and seven in the pipeline.
Further information
Regulatory
READ MORE

Personal Information

Copyright © 2016-2022 PharmaDJ .All Rights Reserved.   Suggestions and feedback: Support@PharmaDJ.com   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement